• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RAD

RADIOPHARM THERANOSTICS LIMITED

7.89% ! 2.1¢
Market Cap $67.34M  !

Radiopharm Theranostics Limited is an Australia-based clinical-stage radiotherapeutics... Radiopharm Theranostics Limited is an Australia-based clinical-stage radiotherapeutics company developing a platform of radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. The Company has a pipeline of highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer. The clinical program includes one Phase II and three Phase I trials in a variety of solid tumor cancers including lung, breast, and brain. Its technologies include Nano-mAbs, Pivalate, AVB6 Integrin, PSA-mAb, and PTPu. Nano-mAbs is a novel radiopharmaceutical platform made using genetic engineered camelid derived single domain antibodies (sdAb) labelled with a radioisotope of therapeutic radiation. Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate which utilizes the early steps of fatty acid oxidation.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RAD
RAD - General Discussions
2 3
13/05/26 154 44K
13/05/26 Last post  inthefreeblue Comments Created with Sketch.  154  Views Created with Sketch.  44K 
RAD 01/05/26 0 334
01/05/26 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  334 
RAD
Preferred External Partner - RAD101
30/04/26 0 224
TRENDING NEWS

On Behalf of Mayfair Gold Corp. Fresnillo Just Paid C$780M. Who Has Five Times the Ounces?

NEWS
15 May 2026
30/04/26 Last post  BioInv2025 Comments Created with Sketch.  0  Views Created with Sketch.  224 
RAD
Company Podcast
28/04/26 1 371
28/04/26 Last post  Cornhulio Comments Created with Sketch.  1  Views Created with Sketch.  371 
RAD
Lantheus last 2 acquisitions vs RAD101
27/04/26 0 251
27/04/26 Last post  BioInv2025 Comments Created with Sketch.  0  Views Created with Sketch.  251 
RAD
8 to 14 cent target price in June
25/04/26 1 575
25/04/26 Last post  inthefreeblue Comments Created with Sketch.  1  Views Created with Sketch.  575 
RAD 23/04/26 3 1.0K
23/04/26 Last post  rover22 Comments Created with Sketch.  3  Views Created with Sketch.  1.0K 
RAD 23/04/26 10 2.4K
23/04/26 Last post  S2jin Comments Created with Sketch.  10  Views Created with Sketch.  2.4K 

See All Discussions arrow Created with Sketch.

Timeline

Financial Services and Company Secretary Changes
01 May 09:53
 
Quarterly Activities/Appendix 4C Cash Flow Report
23 Apr 09:04
 
RAD Initial Findings from Phase 1 177Lu-RAD202 Trial
20 Apr 08:54
 
RAD Completes Enrollment in Phase 2b Trial of RAD 101
16 Apr 08:41
 
RAD202 Phase 1 HEAT Trial Advances to Dose Level 3
08 Apr 09:00
 
RAD and Siemens Sign Clinical Supply Agreement for RAD101
07 Apr 08:31
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Last
2.1¢
Change
0.002(7.89%)
Mkt cap ! $67.34M
Open High Low Volume
1.9¢ 2.1¢ 1.8¢ 4.432M

Buyers (Bids)

Vol. Price($)
107181 2.0¢
 

Sellers (Offers)

Price($) Vol.
2.1¢ 2100271
Last trade - 15.08pm 15/05/2026 (20 minute delay) ?
RAD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.